These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin. Rouy D, Anglés-Cano E. Biochem J; 1990 Oct 01; 271(1):51-7. PubMed ID: 1699517 [Abstract] [Full Text] [Related]
9. The kinetics of plasmin inhibition by aprotinin in vivo. Kang HM, Kalnoski MH, Frederick M, Chandler WL. Thromb Res; 2005 Oct 01; 115(4):327-40. PubMed ID: 15668193 [Abstract] [Full Text] [Related]
11. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis. Lee KN, Jackson KW, McKee PA. Thromb Res; 2002 Feb 01; 105(3):263-70. PubMed ID: 11927133 [Abstract] [Full Text] [Related]
13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH, Diamond SL. Thromb Haemost; 1995 Aug 01; 74(2):711-7. PubMed ID: 8585011 [Abstract] [Full Text] [Related]
16. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII. Rijken DC, Abdul S, Malfliet JJ, Leebeek FW, Uitte de Willige S. J Thromb Haemost; 2016 Jul 01; 14(7):1453-61. PubMed ID: 27148673 [Abstract] [Full Text] [Related]
17. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin. Angles-Cano E, Rouy D, Lijnen HR. Biochim Biophys Acta; 1992 Dec 08; 1156(1):34-42. PubMed ID: 1472536 [Abstract] [Full Text] [Related]
20. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator. Silva MM, Thelwell C, Williams SC, Longstaff C. J Thromb Haemost; 2012 Nov 08; 10(11):2354-60. PubMed ID: 22974122 [Abstract] [Full Text] [Related] Page: [Next] [New Search]